Fig. 9From: Comprehensive analysis of cuproptosis-related lncRNAs in immune infiltration and prognosis in hepatocellular carcinomaChemotherapy drug sensitivity analysis in low- and high-risk groups. a Erlotinib; b lapatinib; c imatinib; d gemcitabine; e paclitaxel; f sunitinibBack to article page